Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-26-015750 General Corporate
Debt relative to revenue 82th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
100.39% · OPTIONAL · VALID
Capex intensity 59th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.62% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.75% · OPTIONAL · VALID
Revenue growth 8th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-6.50% · CORE · VALID
Inventory pressure 71th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
120.74% · OPTIONAL · VALID
Gross margin 6th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
21.31% · CORE · VALID
Operating margin 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-0.45% · CORE · VALID
R&D intensity 82th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.24% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
-0.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 25.97%
Current 100.39%
Delta 74.41% Capex Intensity Decreased
Previous 2.03%
Current 1.62%
Delta -0.40% Cash Generation Decreased
Previous 5.75%
Current 4.75%
Delta -0.99% Growth Decreased
Previous 16.24%
Current -6.50%
Delta -22.74% Inventory Pressure Increased
Previous 28.25%
Current 120.74%
Delta 92.49% Margin Decreased
Previous 24.07%
Current 21.31%
Delta -2.77% Profitability Increased
Previous -3.09%
Current -0.45%
Delta 2.63% R And D Intensity Increased
Previous 5.44%
Current 6.24%
Delta 0.80% Sbc Intensity Decreased
Previous 0.49%
Current -0.00%
Delta -0.49% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.